Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).

× No keyword cloud information.

15 in total

Review 1. Arsenic trioxide - An old drug rediscovered.

Authors: Ashkan Emadi; Steven D Gore
Journal: Blood Rev Date: 2010-05-15 Impact factor: 8.250

2. Therapy-related acute promyelocytic leukemia.

Authors: Farhad Ravandi
Journal: Haematologica Date: 2011-04 Impact factor: 9.941

3. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.

Authors: Yasmin Abaza; Hagop Kantarjian; Guillermo Garcia-Manero; Elihu Estey; Gautam Borthakur; Elias Jabbour; Stefan Faderl; Susan O'Brien; William Wierda; Sherry Pierce; Mark Brandt; Deborah McCue; Rajyalakshmi Luthra; Keyur Patel; Steven Kornblau; Tapan Kadia; Naval Daver; Courtney DiNardo; Nitin Jain; Srdan Verstovsek; Alessandra Ferrajoli; Michael Andreeff; Marina Konopleva; Zeev Estrov; Maria Foudray; David McCue; Jorge Cortes; Farhad Ravandi
Journal: Blood Date: 2016-12-21 Impact factor: 22.113

Review 4. Curing all patients with acute promyelocytic leukemia: are we there yet?

Authors: Muhamed Baljevic; Jae H Park; Eytan Stein; Dan Douer; Jessica K Altman; Martin S Tallman
Journal: Hematol Oncol Clin North Am Date: 2011-12 Impact factor: 3.722

5. Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.

Authors: Farhad Ravandi; Eli Estey; Dan Jones; Stefan Faderl; Susan O'Brien; Jackie Fiorentino; Sherry Pierce; Deborah Blamble; Zeev Estrov; William Wierda; Alessandra Ferrajoli; Srdan Verstovsek; Guillermo Garcia-Manero; Jorge Cortes; Hagop Kantarjian
Journal: J Clin Oncol Date: 2008-12-15 Impact factor: 44.544

6. Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy.

Authors: Mindy Leech; Lawrence Morris; Moishe Stewart; B Douglas Smith; Asad Bashey; Kent Holland; Scott Solomon; Xu Zhang; Hetty E Carraway; Keith Pratz; Steven D Gore; Amer M Zeidan
Journal: Clin Lymphoma Myeloma Leuk Date: 2014-11-15

7. Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.

Authors: Steven D Gore; Ivana Gojo; Mikkael A Sekeres; Lawrence Morris; Marcel Devetten; Katarzyna Jamieson; Robert L Redner; Robert Arceci; Ibitayo Owoeye; Tianna Dauses; Esther Schachter-Tokarz; Robert E Gallagher
Journal: J Clin Oncol Date: 2010-01-19 Impact factor: 44.544

8. A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Authors: Alfonso Quintás-Cardama; Naval Daver; Hawk Kim; Courtney Dinardo; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Sherry Pierce; Jianqin Shan; Marylou Cardenas-Turanzas; Jorge Cortes; Farhad Ravandi; William Wierda; Zeev Estrov; Stefan Faderl; Yue Wei; Hagop Kantarjian; Guillermo Garcia-Manero
Journal: Clin Lymphoma Myeloma Leuk Date: 2014-05-06

9. Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy.

Authors: Farhad Ravandi
Journal: Leuk Lymphoma Date: 2009-07

Review 10. Acute promyelocytic leukemia: where did we start, where are we now, and the future.

Authors: C C Coombs; M Tavakkoli; M S Tallman
Journal: Blood Cancer J Date: 2015-04-17 Impact factor: 11.037